view more →
410 Medical develops innovative resuscitation technologies for emergency and critical care.
view more →
Aer Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class inhaled therapies that target mucus obstruction in chronic lung diseases.
view more →
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.
view more →
AN2 Therapeutics is a clinical-stage biotech company advancing novel small molecule therapeutics.
view more →
Developer of scientific data management software designed to enhance workplace collaboration. Acquired by PerkinElmer (NYS: PKI) in March 2011.
view more →
Providing in-home primary care for seniors with complex conditions, especially those with dementia
view more →
Atsena Therapeutics is a clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal diseases
view more →
Avivomed is a Minneapolis-based medical device company developing next-generation neuromodulation therapies
view more →
Axonis Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule therapies that target KCC2
view more →
Ed-tech platform that pairs high achieving, under-resourced students with mentors to guide them to successful career outcomes
view more →
Their clinical research software accelerates timelines by automating multiple high impact processes.
view more →
Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.
view more →
Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases
view more →
Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies
view more →
Carallel is a digital health company that provides personalized guidance, expert support, and technology tools
view more →
Cardiosense combines multimodal wearable sensors with AI to noninvasively detect early signs of cardiac disease and guide personalized therapy.
view more →
Clearside Biomedical is a biopharmaceutical company focused on revolutionizing treatment for sight-threatening back-of-the-eye diseases. IPO in June, 2016 (NASDAQ:CLSD).
view more →
Clinipace is a clinical research organization whose services are enhanced by a proprietary on-demand software platform and clinical research services. Acquired by dMed in April 2021.
view more →
Developer of an online platform for clinical payments. Acquired by BioClinica on January 19, 2016.
view more →
Code Bio is a preclinical stage company developing novel genetic medicines.
view more →
CREATE Medicines is a clinical-stage biotechnology company pioneering a new class of in vivo immune programming therapies
view more →
Curoverse developed a genomic and biomedical computing platform. Acquired by Veritas Genetics in August 2017.
view more →
CVRx develops an implantable system that delivers baroreflex activation therapy. IPO in June 2021 (NASDAQ: CVRX).
view more →
Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021
view more →
Elligo Health Research is a healthcare-enabling research organization that integrates clinical trials directly into routine patient care
view more →
Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.
view more →
Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.
view more →
Entegrion develops point-of-care hemostasis solutions centered on its Viscoelastic Coagulation Monitor (VCM)
view more →
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company. IPO in May 2017 (NASDAQ: GTHX) Acquired by Pharmacosmos in 2024
view more →
GeneCentric’s mission is to address the urgent unmet need in precision oncology for better biomarkers and to bring these biomarkers to liquid biopsies.
view more →
Gozio Health is a digital health company that provides a customizable, mobile engagement platform for health systems
view more →
Graybug Vision, Inc. was a clinical-stage ophthalmology company developing sustained-release therapies. IPO in September 2020 (NASDAQ: GRAY).
view more →
HistoSonics, Inc. is pioneering a novel, non-invasive therapeutic platform based on histotripsy. Acquired by Bezos Expeditions, Wellington K5 Global 2025
view more →
Huma.AI is a life sciences–focused generative AI company that provides a secure knowledge platform
view more →
MMvention Therapeutix, Inc. is an early-stage biotechnology company focused on discovering and developing novel oral small-molecule therapeutics
view more →
Engages patients and families in a personalized way to initiate discussions on end-of-life care planning. Acquired by Aledade in January 2022.
view more →
iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software
view more →
Founded by pediatricians, developing medical content in an educational format embraced by children. Acquired by Falfurrias 2024
view more →
Kymera Therapeutics, Inc. is a clinical-stage biotechnology company pioneering targeted protein degradation. IPO in August 2020 (NASDAQ: KYMR).
view more →
Developer of innovative neurodegeneration small-molecules intended to establish a platform for novel drug discovery.Acquired by Bial in October 2020.
view more →
Provider of patient experience platform designed to facilitate the relationship between physicians and patients. Acquired by NextGen 2019
view more →
Mercy BioAnalytics is a biotechnology company developing blood-based tests for the early detection of cancer
view more →
Operator of a biopharmaceutical agency intended to offer drugs for the treatment of diabetes and other metabolic disorders.
view more →
Developer of staffing, communication and schedule management tools designed to modernize staffing processes. Acquired by HealthStream 2020
view more →
The Company’s lead product candidate, PB2452, is a novel reversal agent for the antiplatelet drug ticagrelor. IPO in October, 2018 (NASDAQ:PHAS)
view more →
Perfuse Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapies to improve retinal blood flow and treat ischemia-driven eye diseases.
view more →
Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.
view more →
Qpex Biopharma is a clinical-stage biopharmaceutical company developing novel anti-infective therapies. Acquired by Shionogi 2023
view more →
RapidPulse is a medical device company developing an innovative, minimally invasive vascular system for treating acute ischemic stroke.
view more →
Ribometrix is a biotechnology company pioneering a new class of small-molecule therapeutics that directly target the three-dimensional structures of RNA to modulate disease biology.
view more →
Rodin Therapeutics was a biotechnology company focused on discovering and developing first-in-class small molecule therapeutics. Acquired by ALKS in Nov 2019
view more →
Rx Redefined is a healthcare technology company that provides a compliance-focused platform
view more →
SafeRide Health is a healthcare technology and services company that improves access to care by coordinating non-emergency medical transportation for vulnerable populations.
view more →
Shattuck Labs is a clinical-stage biotechnology company advancing novel biologic medicines for inflammatory and immune-mediated diseases. IPO in October 2020 (NASDAQ: STTK)
view more →
Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023
view more →
Sensorium Therapeutics is a clinical-stage biotechnology company developing next-generation brain and mental health medicines.
view more →
Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain
view more →
Ten63 Therapeutics is a computational drug discovery company leveraging its proprietary AI- and physics-based platform to design novel therapeutics
view more →
Trefoil Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to restore vision for people with corneal diseases.
view more →
Tune Therapeutics is a biotechnology innovator advancing a new class of epi-therapeutic medicines
view more →
The company’s lead drug has potential to be a game-changer in the treatment of HITT. Acquired by Cadrenal Therapeutics 2025
view more →
Viamet Pharmaceuticals is a biotechnology company. Acquired by NovaQuest Capital Management in January 2018.
view more →
Vigil Neuroscience is a clinical-stage biotechnology company. IPO in January 2022 (NASDAQ: VIGL). Acquired by Sanofi in 2025.
view more →
Vircho is a healthcare technology company that connects healthcare organizations with community-based social services
view more →
Wesper is a digital health company developing an FDA-cleared, at-home sleep testing platform that delivers clinical-grade diagnostics for sleep disorders
